Twist Bioscience (TWST) Gross Profit (2017 - 2026)

Twist Bioscience (TWST) has 10 years of Gross Profit data on file, last reported at $57.1 million in Q1 2026.

• Gross Profit for Q1 2026 came in at $57.1 million, up 24.1% year-over-year; the trailing twelve-month figure through Mar 2026 was $213.2 million (up 31.32% YoY), and the FY2025 annual result was $191.0 million, up 43.23% from the prior year.
• Gross Profit grew to $57.1 million in Q1 2026 per TWST's latest filing, from $54.0 million in the prior quarter.
• Over five years, Gross Profit peaked at $57.1 million in Q1 2026 and troughed at $18.4 million in Q1 2022.
• A 5-year average of $35.0 million and a median of $30.9 million in 2024 frame the typical range for Gross Profit.
• The sharpest annual moves came in 2022 and 2023: Gross Profit jumped 78.48% in 2022, then retreated 12.9% in 2023.
• A 5-year view of Gross Profit shows it stood at $24.8 million in 2022, then rose by 16.78% to $29.0 million in 2023, then soared by 47.92% to $42.8 million in 2024, then increased by 25.99% to $54.0 million in 2025, then advanced by 5.84% to $57.1 million in 2026.
• Business Quant data shows TWST's Gross Profit at $57.1 million in Q1 2026, $54.0 million in Q4 2025, and $50.8 million in Q3 2025.